Veterinary Medicines

Stullmisan vet. Pulver

Authorised
  • Abies sibirica extract
Download as PDF

Product identification

Medicine name:
Stullmisan vet. Pulver
Active substance:
  • Abies sibirica extract
Target species:
  • Quail
  • Turkey
  • Cattle
  • Chicken
  • Chicken (for reproduction)
  • Cattle (pre-ruminant)
  • Dog
  • Sheep
  • Horse
  • Cat
  • Guinea pig
  • Hamster
  • Pig (suckling piglet)
  • Horse (foal)
  • Rabbit (non food-producing)
  • Pig (piglet)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Abies sibirica extract
    30.56
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Quail
      • Egg
        0
        day
      • Meat and offal
        1
        day
    • Turkey
      • Egg
        0
        day
      • Meat and offal
        1
        day
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        1
        day
    • Chicken
    • Chicken (for reproduction)
      • Meat and offal
        1
        day
      • Egg
        0
        day
    • Cattle (pre-ruminant)
      • Meat and offal
        1
        day
    • Dog
    • Sheep
      • Meat and offal
        1
        day
      • Milk
        1
        day
    • Horse
      • Meat and offal
        1
        day
      • Milk
        1
        day
    • Cat
    • Guinea pig
    • Hamster
    • Pig (suckling piglet)
      • Meat and offal
        1
        day
    • Horse (foal)
      • Meat and offal
        1
        day
    • Rabbit (non food-producing)
    • Pig (piglet)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharma Stulln GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharma Stulln GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401262.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (RTF)
Published on: 2/09/2024
Download

2401262-parde-20100614.pdf

German (PDF)
Published on: 2/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."